ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,646, issued on July 29, was assigned to CureVac Manufacturing GmbH (Tubingen, Germany) and Tesla Automation GmbH (Prum, Germany).
"Bioreactor for RNA in vitro transcription" was invented by Benyamin Yazdan Panah (Tubingen, Germany), Tilmann Roos (Tubingen, Germany), Martin Kunze (Tubingen, Germany), Felix Bertsch (Tubingen, Germany), Aniela Wochner (Tubingen, Germany), Michael Rauen (Tubingen, Germany) and Philipp Hoffmann (Tubingen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a bioreactor for RNA in vitro transcription, a method for RNA in vitro transcription, a module for transcribing DNA into RNA and an...